Barrett's esophagus in the patients with familial adenomatous polyposis

Zoran Gatalica, Mingkui Chen, Carrie Snyder, Sumeet Mittal, Henry T. Lynch

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Familial adenomatous polyposis (FAP) is caused by germ line mutations in the APC gene. Barrett's esophagus (BE) and Barrett's adenocarcinoma are intestinal type lesions of the esophagus characterized by an early loss of heterozygosity at the APC locus. We hypothesized that patients with FAP are at risk for the early development of BE due to the inherited mutations in the APC gene (haploinsufficiency). Upper gastrointestinal (UGI) tract biopsies from 36 patients with FAP were reviewed to determine the incidence and characteristics of BE in these patients. Twenty-four patients were confirmed carriers of a deleterious germline APC mutation. The other 12 patients were from FAP families with known APC gene mutations and had clinical manifestations of FAP. The control group consisted of patients who did not have a personal or family history of FAP undergoing UGI endoscopic examination in our institution over a 30 month period of time. The difference in expression of Wnt pathway proteins (APC, β-catenin, E-cadherin and cyclin D1) in BE between BE +/FAP+, BE-/FAP+ and age-matched BE+/FAP- groups was studied using immunohistochemistry. BE was found in 6 of 36 (6/36 or 16%) patients with FAP and in 266 of 1662 patients (16%) in the control group of symptomatic patients. The average age at the first diagnosis of BE in FAP patients was 37.8 versus 57.5 years in the control group (sporadic BE). When compared to age matched BE+/FAP- group (7/334), patients with FAP had a significantly (p = 0.005843, odds ratio 9.2; Fisher exact test) higher incidence of BE. Both classic FAP and attenuated FAP phenotypes were associated with BE .Two types of germ line mutations in APC gene were identified in BE+/FAP+ patients: Five patients had 2-base deletion in exon 4 (426delAT) and one patient had 4-base deletion in exon 15 (3202del4). No difference in Wnt signaling pathway proteins expression was detected between BE+/FAP+ and the age matched group of patients with sporadic BE (BE+/FAP-). Patients with FAP appear to have increased risk for the development of BE, which on average develops some 20 years earlier than in patients without FAP. This association needs to be taken in account when caring for the patients with FAP.

Original languageEnglish
Pages (from-to)213-217
Number of pages5
JournalFamilial Cancer
Volume13
Issue number2
DOIs
StatePublished - 2014

Fingerprint

Adenomatous Polyposis Coli
Barrett Esophagus
APC Genes
Germ-Line Mutation
Wnt Signaling Pathway
Control Groups
Exons
Wnt Proteins
Haploinsufficiency
Catenins
Mutation

All Science Journal Classification (ASJC) codes

  • Oncology
  • Genetics(clinical)
  • Cancer Research
  • Genetics
  • Medicine(all)

Cite this

Barrett's esophagus in the patients with familial adenomatous polyposis. / Gatalica, Zoran; Chen, Mingkui; Snyder, Carrie; Mittal, Sumeet; Lynch, Henry T.

In: Familial Cancer, Vol. 13, No. 2, 2014, p. 213-217.

Research output: Contribution to journalArticle

Gatalica, Zoran ; Chen, Mingkui ; Snyder, Carrie ; Mittal, Sumeet ; Lynch, Henry T. / Barrett's esophagus in the patients with familial adenomatous polyposis. In: Familial Cancer. 2014 ; Vol. 13, No. 2. pp. 213-217.
@article{ca111c52d8fa4996b0c36db17dffda9c,
title = "Barrett's esophagus in the patients with familial adenomatous polyposis",
abstract = "Familial adenomatous polyposis (FAP) is caused by germ line mutations in the APC gene. Barrett's esophagus (BE) and Barrett's adenocarcinoma are intestinal type lesions of the esophagus characterized by an early loss of heterozygosity at the APC locus. We hypothesized that patients with FAP are at risk for the early development of BE due to the inherited mutations in the APC gene (haploinsufficiency). Upper gastrointestinal (UGI) tract biopsies from 36 patients with FAP were reviewed to determine the incidence and characteristics of BE in these patients. Twenty-four patients were confirmed carriers of a deleterious germline APC mutation. The other 12 patients were from FAP families with known APC gene mutations and had clinical manifestations of FAP. The control group consisted of patients who did not have a personal or family history of FAP undergoing UGI endoscopic examination in our institution over a 30 month period of time. The difference in expression of Wnt pathway proteins (APC, β-catenin, E-cadherin and cyclin D1) in BE between BE +/FAP+, BE-/FAP+ and age-matched BE+/FAP- groups was studied using immunohistochemistry. BE was found in 6 of 36 (6/36 or 16{\%}) patients with FAP and in 266 of 1662 patients (16{\%}) in the control group of symptomatic patients. The average age at the first diagnosis of BE in FAP patients was 37.8 versus 57.5 years in the control group (sporadic BE). When compared to age matched BE+/FAP- group (7/334), patients with FAP had a significantly (p = 0.005843, odds ratio 9.2; Fisher exact test) higher incidence of BE. Both classic FAP and attenuated FAP phenotypes were associated with BE .Two types of germ line mutations in APC gene were identified in BE+/FAP+ patients: Five patients had 2-base deletion in exon 4 (426delAT) and one patient had 4-base deletion in exon 15 (3202del4). No difference in Wnt signaling pathway proteins expression was detected between BE+/FAP+ and the age matched group of patients with sporadic BE (BE+/FAP-). Patients with FAP appear to have increased risk for the development of BE, which on average develops some 20 years earlier than in patients without FAP. This association needs to be taken in account when caring for the patients with FAP.",
author = "Zoran Gatalica and Mingkui Chen and Carrie Snyder and Sumeet Mittal and Lynch, {Henry T.}",
year = "2014",
doi = "10.1007/s10689-013-9638-7",
language = "English",
volume = "13",
pages = "213--217",
journal = "Familial Cancer",
issn = "1389-9600",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Barrett's esophagus in the patients with familial adenomatous polyposis

AU - Gatalica, Zoran

AU - Chen, Mingkui

AU - Snyder, Carrie

AU - Mittal, Sumeet

AU - Lynch, Henry T.

PY - 2014

Y1 - 2014

N2 - Familial adenomatous polyposis (FAP) is caused by germ line mutations in the APC gene. Barrett's esophagus (BE) and Barrett's adenocarcinoma are intestinal type lesions of the esophagus characterized by an early loss of heterozygosity at the APC locus. We hypothesized that patients with FAP are at risk for the early development of BE due to the inherited mutations in the APC gene (haploinsufficiency). Upper gastrointestinal (UGI) tract biopsies from 36 patients with FAP were reviewed to determine the incidence and characteristics of BE in these patients. Twenty-four patients were confirmed carriers of a deleterious germline APC mutation. The other 12 patients were from FAP families with known APC gene mutations and had clinical manifestations of FAP. The control group consisted of patients who did not have a personal or family history of FAP undergoing UGI endoscopic examination in our institution over a 30 month period of time. The difference in expression of Wnt pathway proteins (APC, β-catenin, E-cadherin and cyclin D1) in BE between BE +/FAP+, BE-/FAP+ and age-matched BE+/FAP- groups was studied using immunohistochemistry. BE was found in 6 of 36 (6/36 or 16%) patients with FAP and in 266 of 1662 patients (16%) in the control group of symptomatic patients. The average age at the first diagnosis of BE in FAP patients was 37.8 versus 57.5 years in the control group (sporadic BE). When compared to age matched BE+/FAP- group (7/334), patients with FAP had a significantly (p = 0.005843, odds ratio 9.2; Fisher exact test) higher incidence of BE. Both classic FAP and attenuated FAP phenotypes were associated with BE .Two types of germ line mutations in APC gene were identified in BE+/FAP+ patients: Five patients had 2-base deletion in exon 4 (426delAT) and one patient had 4-base deletion in exon 15 (3202del4). No difference in Wnt signaling pathway proteins expression was detected between BE+/FAP+ and the age matched group of patients with sporadic BE (BE+/FAP-). Patients with FAP appear to have increased risk for the development of BE, which on average develops some 20 years earlier than in patients without FAP. This association needs to be taken in account when caring for the patients with FAP.

AB - Familial adenomatous polyposis (FAP) is caused by germ line mutations in the APC gene. Barrett's esophagus (BE) and Barrett's adenocarcinoma are intestinal type lesions of the esophagus characterized by an early loss of heterozygosity at the APC locus. We hypothesized that patients with FAP are at risk for the early development of BE due to the inherited mutations in the APC gene (haploinsufficiency). Upper gastrointestinal (UGI) tract biopsies from 36 patients with FAP were reviewed to determine the incidence and characteristics of BE in these patients. Twenty-four patients were confirmed carriers of a deleterious germline APC mutation. The other 12 patients were from FAP families with known APC gene mutations and had clinical manifestations of FAP. The control group consisted of patients who did not have a personal or family history of FAP undergoing UGI endoscopic examination in our institution over a 30 month period of time. The difference in expression of Wnt pathway proteins (APC, β-catenin, E-cadherin and cyclin D1) in BE between BE +/FAP+, BE-/FAP+ and age-matched BE+/FAP- groups was studied using immunohistochemistry. BE was found in 6 of 36 (6/36 or 16%) patients with FAP and in 266 of 1662 patients (16%) in the control group of symptomatic patients. The average age at the first diagnosis of BE in FAP patients was 37.8 versus 57.5 years in the control group (sporadic BE). When compared to age matched BE+/FAP- group (7/334), patients with FAP had a significantly (p = 0.005843, odds ratio 9.2; Fisher exact test) higher incidence of BE. Both classic FAP and attenuated FAP phenotypes were associated with BE .Two types of germ line mutations in APC gene were identified in BE+/FAP+ patients: Five patients had 2-base deletion in exon 4 (426delAT) and one patient had 4-base deletion in exon 15 (3202del4). No difference in Wnt signaling pathway proteins expression was detected between BE+/FAP+ and the age matched group of patients with sporadic BE (BE+/FAP-). Patients with FAP appear to have increased risk for the development of BE, which on average develops some 20 years earlier than in patients without FAP. This association needs to be taken in account when caring for the patients with FAP.

UR - http://www.scopus.com/inward/record.url?scp=84903308549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903308549&partnerID=8YFLogxK

U2 - 10.1007/s10689-013-9638-7

DO - 10.1007/s10689-013-9638-7

M3 - Article

VL - 13

SP - 213

EP - 217

JO - Familial Cancer

JF - Familial Cancer

SN - 1389-9600

IS - 2

ER -